Your browser doesn't support javascript.
loading
COVID-19 rapid diagnostics: practice review.
Reynard, Charles; Allen, Joy A; Shinkins, Bethany; Prestwich, Graham; Goves, Johnathan; Davies, Kerrie; Body, Richard.
Afiliação
  • Reynard C; Emergency Department, Manchester University NHS Foundation Trust, Manchester, UK charlie.reynard@nhs.net.
  • Allen JA; Division of Cardiovascular Sciences, The University of Manchester, Manchester, UK.
  • Shinkins B; NIHR Newcastle In Vitro Diagnostics Co-operative, Translational and Clinical Research Institute, Newcastle University School of Clinical Medical Sciences, Newcastle University, Tyne and Wear, UK.
  • Prestwich G; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • Goves J; Test Evaluation Group, Leeds Institute for Health Sciences, University of Leeds, Leeds, UK.
  • Davies K; Patient and Public Involvement, Yorkshire and Humber Academic Health Science Networks, Leeds, UK.
  • Body R; Division of Cardiovascular Sciences, The University of Manchester, Manchester, UK.
Emerg Med J ; 39(1): 70-76, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34740887
ABSTRACT
Point-of-care tests for SARS-CoV-2 could enable rapid rule-in and/or rule-out of COVID-19, allowing rapid and accurate patient cohorting and potentially reducing the risk of nosocomial transmission. As COVID-19 begins to circulate with other more common respiratory viruses, there is a need for rapid diagnostics to help clinicians test for multiple potential causative organisms simultaneously.However, the different technologies available have strengths and weaknesses that must be understood to ensure that they are used to the benefit of the patient and healthcare system. Device performance is related to the deployed context, and the diagnostic characteristics may be affected by user experience.This practice review is written by members of the UK's COVID-19 National Diagnostic Research and Evaluation programme. We discuss relative merits and test characteristics of various commercially available technologies. We do not advocate for any given test, and our coverage of commercially supplied tests is not intended to be exhaustive.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article